X2KA30A
Bypass Atrium, Left to New Technology Group 10 with Conduit through Coronary Sinus to Right Atrium, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 2 Cardiovascular System |
| Operation | K Bypass |
| Body Part | A Atrium, Left |
| Approach | 3 Percutaneous |
| Device | 0 Conduit through Coronary Sinus to Right Atrium |
| Qualifier | A New Technology Group 10 |
Operation Definition
Altering the route of passage of the contents of a tubular body part
Procedure Overview
This family covers rerouting blood flow around a diseased or blocked vessel using a new technology conduit or device not yet captured by standard bypass codes. Traditional coronary or peripheral bypass uses a harvested vein or synthetic graft; procedures in this group involve a novel material or delivery method that has been granted distinct New Technology status, such as an engineered conduit designed to improve long-term patency. The clinical goal remains the same as any bypass: restoring adequate blood supply to tissue starved by an obstruction.
Patients undergoing these procedures are often part of a defined population where the newer conduit or technique has shown a specific advantage, such as reduced graft failure, over conventional grafting materials.
Anatomy & Axis Detail
Atrium, Left
The left atrium receives oxygenated blood from the pulmonary veins and, in conditions such as heart failure with preserved ejection fraction, can develop chronically elevated filling pressures that back up into the lungs. A New Technology bypass procedure here typically involves permanently establishing a controlled channel between the left atrium and an adjacent chamber, most often the right atrium, using an implanted shunt device rather than a traditional vascular conduit. This interatrial shunt decompresses the overloaded left atrium during exertion, redirecting a portion of its pressure and volume load to the lower-pressure right side of the heart. Documentation should reflect the device used and confirm that flow is being diverted away from the left atrium's native outflow rather than repaired or restricted.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Conduit through Coronary Sinus to Right Atrium
This value specifies a device pathway routed through the coronary sinus into the right atrium, describing the anatomic course taken to reach or connect with a target structure, such as a coronary sinus reducer or related device. It is distinguished from other conduit routes, like those through peripheral veins to arteries, by its cardiac venous anatomy. The value documents the access route rather than the device's therapeutic mechanism.
Qualifier: New Technology Group 10
New Technology Group 10 flags a procedure as part of the 2023 batch of add-on codes recognized under the New Technology section. The value itself carries no information about the device or drug involved; that comes from the table, body part, and approach values alongside it. Coders should not confuse it with Group 9 or Group 11, which cover the cohorts approved in the years immediately before and after.
Coding & Documentation
Coders must confirm the operative report names the specific device or conduit listed in the New Technology reference table, along with the two body parts connected by the bypass, since the code identifies both the origin and the route of the rerouted flow. A frequent assignment error is selecting the standard section Bypass code when the graft material actually qualifies for New Technology designation, or reversing the coded direction of blood flow described in the qualifier. Documentation should also clearly distinguish a true bypass, which creates an alternate route while leaving the diseased segment in place, from removal or replacement of the diseased segment itself.
Commonly Confused With
This family is frequently confused with standard Cardiovascular Bypass procedures, where the deciding factor is exclusively whether the conduit or device is included in the current New Technology table. It also differs from Replacement, since a bypass leaves the original diseased vessel in place and adds an alternate route rather than substituting the vessel's structure.